Impact of Periodontal Treatment on the RANKL/OPG Ratio in Crevicular Fluid
1 other identifier
observational
40
0 countries
N/A
Brief Summary
Objectives: Alveolar resorption is one of the most important events in periodontitis. Osteoclast activity is regulated by the ratio between receptor activator of NF-κB ligand (RANKL) and osteoprotegerin (OPG). The aim of this study was to evaluate changes in the RANKL/OPG ratio in crevicular fluid after periodontal treatment. Material and methods: A total of 15 patients with periodontitis were included in the study group. Samples were collected from an area with active periodontitis and a healthy area. The RANKL and OPG levels were measured before and after periodontal scaling and root planing (SRP) treatment. The study group was compared to the control group, which included 10 patients without periodontitis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Feb 2016
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 2, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 5, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
November 6, 2016
CompletedFirst Submitted
Initial submission to the registry
December 21, 2018
CompletedFirst Posted
Study publicly available on registry
December 26, 2018
CompletedDecember 26, 2018
December 1, 2018
4 months
December 21, 2018
December 24, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Levels of RANKL in crevicular fluid
receptor activator of NF-κB ligand.RANKL is a protein that determines the activation of osteoclasts by binding to the RANK membrane receptor that preosteoclates possess. The ranks wi be measured in μg / μl.
49 days
Levels of OPG in crevicular fluid
osteoprotegerin.Osteoprogesterian is a soluble protein that acts as a decoy blocked RANK receptor and thus initiating osteoclastogenesis. The opg will be measured in μg / μl.
49 days
Secondary Outcomes (3)
probing depth
49 days
clinical attachment level
49 days
bleeding upon probing
49 days
Study Arms (2)
Control
The control group included 10 periodontally healthy subjects without signs or symptoms of periodontal disease.
Study
The study group included 15 subjects diagnosed with mild or advanced chronic periodontitis. Each periodontal patient had one non-affected single-rooted tooth (healthy site) and another single-rooted tooth with periodontitis (periodontitis site) with the following features: Healthy site: a single-rooted tooth with probing depths below or equal to 3 mm without recession and without bleeding on probing. Periodontitis site: another single-rooted tooth from the same patient with clinical attachment loss equal to or greater than 6 mm and bleeding upon probing.
Interventions
In the study group, periodontal scaling and root planning treatment of the 4 quadrants was performed for two consecutive weeks without the use of antiseptics or antibiotics, and the patients were instructed in oral hygiene, including both brushing techniques and proximal hygiene.
Eligibility Criteria
The study population is the classic refreshing race of the population of Spain.
You may qualify if:
- The control group included:
- periodontally healthy subjects
- Without signs or symptoms of periodontal disease.
- The study group included:
- subjects diagnosed with mild or advanced chronic periodontitis.
- One non-affected single-rooted tooth (healthy site)
- Single-rooted tooth with periodontitis (periodontitis site) with the following features: with clinical attachment loss equal to or greater than 6 mm and bleeding upon probing.
You may not qualify if:
- Subjects with aggressive periodontitis
- Systemic diseases or consumption of drugs affecting bone metabolism
- Antibiotic, anti-inflammatory or contraceptive treatment for the last three months prior to study initiation
- Antiplatelet therapy for the last 7 days prior to study onset
- Primary or secondary occlusal trauma
- Periapical or periodontal abscess in some of the teeth included in the study
- Periodontal treatment within the last 6 months
- Orthodontic treatment
- Smoking
- Pregnant or breastfeeding.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (1)
Lopez Roldan A, Garcia Gimenez JL, Alpiste Illueca F. Impact of periodontal treatment on the RANKL/OPG ratio in crevicular fluid. PLoS One. 2020 Jan 27;15(1):e0227757. doi: 10.1371/journal.pone.0227757. eCollection 2020.
PMID: 31986169DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate professor
Study Record Dates
First Submitted
December 21, 2018
First Posted
December 26, 2018
Study Start
February 2, 2016
Primary Completion
June 5, 2016
Study Completion
November 6, 2016
Last Updated
December 26, 2018
Record last verified: 2018-12
Data Sharing
- IPD Sharing
- Will not share